Samsung has declared that it is working to search and monitor the left ventricular systolic dysfunction (LVSD). It is a serious cardiovascular and cardiovascular condition that is responsible for approximately 50% of all cases of heart failure and is more fatal than some cancer.
Thus, it is important to find out early to reduce the risk of death and to reduce the hospital. The Korean Medical Device Company, a specialist in the AI-based ECG, will use the AI algorithm developed in collaboration with Medical AI. The algorithm was developed on the basis of the in-house algorithm of Medical AI for 12-ECG analysis, which is deployed in more than 100 larger hospitals in Korea and used for more than 120,000 patients.
The technology enables early examination for acemptomatic people and also reduces health care related to heart failure by promoting early diagnosis and timely treatment.
Samsung has partnered with the Biomedical Engineering Department of the Haniang University to develop a near-IG prototype device, which aims to overcome the limitations of the traditional EEG system, which allows a “a cute, ergonomic design that allows continuous brainwave monitoring outside the laboratory settings”. It captures high-quality signals from the ears strategically placed in the ears.
Real-time’s accurate examination of fitness and AI brainwave analysis “AI Brainweve Analysis” and AI Brainweave Analysis “directed to the possible applications of” neuromacketing and entertainment “.
Both of them have no release date. Finding and monitoring LVSD is a more mature technology, so in the future you should first look at this in the real world.
